Literature DB >> 2281818

Non-specific cholinesterase activity of the developing peripheral nerves and its possible function in cells in intimate contact with growing axons of chick embryo.

P Dubovy1, P Haninec.   

Abstract

The results presented here demonstrate non-specific cholinesterase (nChE) activity in the developing peripheral nerves of chick embryos at stages 25-26 according to Hamburger and Hamilton (1951, J. Morphol. 88, 49-92). Under the light microscope the use of simultaneous staining for nChE activity and silver proteinate impregnation revealed the axons to be surrounded by cells exhibiting nChE activity in the main nerve trunks and in the growing tips of nerves. Nerve branches arising from the main nerve trunks contained cells with positive reaction for nChE activity, too. Electron-dense particles of the reaction product indicating nChE activity were found in the rough endoplasmic reticulum and in the perinuclear envelope of cells in close contact with growing nerve fibers and their growth cones. The same distribution of nChE activity was found in cells which were located near to nerve fasciculi but without direct contact with axons. Surprisingly, the cells in close contact with axons and their growth cones exhibited the end product of nChE activity in the outer part of their plasma membrane. The cells enveloping axons within the nerve trunks were apparently Schwann cells, while those around the growth cones at nerve tips could be identified as Schwann cells and/or mesenchymal cells of the hindlimb. The nChE reaction product was also detected in the axolemma of nerve fibers and their growth cones. The distribution of nChE activity in the developing peripheral nerves of chick embryos suggests that these molecules may influence the process of axonal elongation and locomotion. Several possible mechanisms of nChE action on growing axons can be presumed: (i) intracellular Ca2+ level regulation; (ii) providing an adhesive substrate; and (iii) butyrate production affecting the cell metabolism and the distribution of neurotubules and neurofilaments. It is also assumed that nChE molecules are involved in the interactions of nerve fibers with Schwann cells and/or mesenchymal cells as well as in interneuronal interactions.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2281818     DOI: 10.1016/0736-5748(90)90051-3

Source DB:  PubMed          Journal:  Int J Dev Neurosci        ISSN: 0736-5748            Impact factor:   2.457


  6 in total

1.  Cranial nerve growth in birds is preceded by cholinesterase expression during neural crest cell migration and the formation of an HNK-1 scaffold.

Authors:  P G Layer; S Kaulich
Journal:  Cell Tissue Res       Date:  1991-09       Impact factor: 5.249

2.  Acetyl- and butyrylcholinesterase in normal and diabetic rat retina.

Authors:  G Sánchez-Chávez; R Salceda
Journal:  Neurochem Res       Date:  2001-02       Impact factor: 3.996

3.  Chicken retinospheroids as developmental and pharmacological in vitro models: acetylcholinesterase is regulated by its own and by butyrylcholinesterase activity.

Authors:  P G Layer; T Weikert; E Willbold
Journal:  Cell Tissue Res       Date:  1992-06       Impact factor: 5.249

4.  Homocysteine inhibits butyrylcholinesterase activity in rat serum.

Authors:  Francieli M Stefanello; Alexandra I Zugno; Clovis M D Wannmacher; Moacir Wajner; Angela T S Wyse
Journal:  Metab Brain Dis       Date:  2003-09       Impact factor: 3.584

5.  In vitro homocysteine inhibits platelet Na+,K+-ATPase and serum butyrylcholinesterase activities of young rats.

Authors:  Francieli M Stefanello; Renata Franzon; Clovis M D Wannmacher; Moacir Wajner; Angela T S Wyse
Journal:  Metab Brain Dis       Date:  2003-12       Impact factor: 3.584

6.  Plasma cholinesterase is associated with Chinese adolescent overweight or obesity and metabolic syndrome prediction.

Authors:  Yanshuo Han; Yanan Ma; Yang Liu; Zhongyi Zhao; Shihan Zhen; Xuelian Yang; Zhiyong Xu; Deliang Wen
Journal:  Diabetes Metab Syndr Obes       Date:  2019-05-14       Impact factor: 3.168

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.